The HEAT trial: A protocol for a multicentre randomised placebo-controlled trial of IV paracetamol in ICU patients with fever and infection

Critical Care and Resuscitation

Volumn 14, Issue 4, 2012, Pages 290-296

  Young, Paul J ^a,b   Saxena, Manoj K ^c,d   Bellomo, Rinaldo ^e   Freebairn, Ross C ^f   Hammond, Naomi E ^c   van Haren, Frank M P ^g   Henderson, Seton J ^h   McArthur, Colin J ⁱ   McGuinness, Shay P ⁱ   Mackle, Diane ^a   Myburgh, John A ^c   Weatherall, Mark ^j   Webb, Steve A R ^k   Beasley, Richard W ^b  

^a WELLINGTON HOSPITAL   (New Zealand)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^c GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^d ST GEORGE HOSPITAL   (Australia)

^e AUSTIN HOSPITAL   (Australia)

^f HAWKE S BAY HOSPITAL   (New Zealand)

^g CANBERRA HOSPITAL   (Australia)

^h CHRISTCHURCH HOSPITAL   (New Zealand)

ⁱ AUCKLAND CITY HOSPITAL   (New Zealand)

^j UNIVERSITY OF OTAGO   (New Zealand)

^k ROYAL PERTH HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; PARACETAMOL;

ADULT; ARTICLE; FEVER; HUMAN; INFECTION; INFORMATION PROCESSING; INTRAVENOUS ADMINISTRATION; METHODOLOGY; MULTICENTER STUDY (TOPIC); NEW ZEALAND; PHASE 2 CLINICAL TRIAL (TOPIC); PILOT STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ACETAMINOPHEN; ADMINISTRATION, INTRAVENOUS; ADULT; ANTIPYRETICS; CLINICAL TRIALS, PHASE II AS TOPIC; DATA COLLECTION; FEVER; HUMANS; INFECTION; MULTICENTER STUDIES AS TOPIC; NEW ZEALAND; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84873168967     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jefferies S, Saxena M, Young P. Paracetamol in critical illness: a review. Crit Care Resusc 2012; 14: 74-80.
2. Selladurai S, Eastwood GM, Bailey M, Bellomo R. Paracetamol therapy for septic critically ill patients: a retrospective observational study. Crit Care Resusc 2011; 13: 181-6.
3. Saxena MK, Hammond NE, Taylor C, et al. A survey of fever management for febrile intensive care patients without neurological injury. Crit Care Resusc 2011; 13: 238-43.
4. Young P, Saxena M, Eastwood GM, et al. Fever and fever management among intensive care patients with known or suspected infection: a multicentre prospective cohort study. Crit Care Resusc 2011; 13: 97-102.
5. Young PJ, Saxena MK, Beasley RW. Fever and antipyresis in infection. Med J Aust 2011; 195: 458-9.
6. Mackowiak PA. Fever: blessing or curse? A unifying hypothesis. Ann Intern Med 1994; 120: 1037-40.
7. Kluger MJ, Kozak W, Conn CA, et al. The adaptive value of fever. Infect Dis Clin North Am 1996; 10: 1-20.
8. Kurosawa S, Kobune F, Okuyama K, Sugiura A. Effects of antipyretics in rinderpest virus infection in rabbits. J Infect Dis 1987; 155: 991-7.
9. Vaughn LK, Veale WL, Cooper KE. Antipyresis: its effect on mortality rate of bacterially infected rabbits. Brain Res Bull 1980; 5: 69-73.
10. van der Zee CE, van Dam RH, Dwinger RH, et al. Flurbiprofen and immunosuppression of Trypanosoma brucei infection in the goat. Vet Immunol Immunopathol 1985; 8: 341-50.
11. Eyers S, Weatherall M, Shirtcliffe P, et al. The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med 2010; 103: 403-11.
12. Jefferies S, Weatherall M, Young P, et al. Systematic review and meta-analysis of the effects of antipyretic medications on mortality in Streptococcus pneumoniae infections. Postgrad Med J 2012; 88: 21-7.
13. Doran TF, De Angelis C, Baumgardner RA, Mellits ED. Acetaminophen: more harm than good for chickenpox? J Pediatr 1989; 114: 1045-8.
14. Brandts CH, Ndjave M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997; 350: 704-9.
15. Graham NM, Burrell CJ, Douglas RM, et al. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis 1990; 162: 1277-82.
16. Young PJ, Saxena M, Beasley R, et al. Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med 2012; 38: 437-44.
17. Schortgen F, Clabault K, Katsahian S, et al. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med 2012; 185: 1088-95.
18. Horvath SM, Spurr GB, Hutt BK, Hamilton LH. Metabolic cost of shivering. J Appl Physiol 1956; 8: 595-602.
19. Greisman SE. Cardiovascular alterations during fever. In: Mackowiak PA, editor. Fever: basic mechanisms and management. 2nd ed. Philadelphia: Lippincott-Raven, 1997: 143-65.
20. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997; 336: 912-8.
21. Lee BH, Inui D, Suh GY, et al. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care 2012; 16: R33.
22. Jefferies S, Weatherall M, Young P, et al. The effect of antipyretic medications on mortality in critically ill patients with infection: a systematic review and meta-analysis. Crit Care Resusc 2011; 13: 125-31.
23. Schulman CI, Namias N, Doherty J, et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect (Larchmt) 2005; 6: 369-75.
24. Hammond NE, Saxena M, Young P, et al. Temperature management for patients without brain injury in Australian and New Zealand ICUs: a point prevalence study [poster presentation]. Crit Care 2012; 16 Suppl 1: P58.
25. Greer DM, Funk SE, Reaven NL, et al. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive metaanalysis. Stroke 2008; 39: 3029-35.
26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.